logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • Industry Trends
  • Technological Frontier
  • Information of YuanVore
Location: Home > News > Industry Trends
  • 基于生物材料的心脏类器官研究进展
    19
    2023-07
    2023-07-19
  • QN-019a——中国第一个获CDE临床试验默示许可的基因编辑iPSC来源的细胞治疗产品
    18
    2023-07
    2023-07-18
  • 沙利文发布:诱导多能干细胞(iPSC)产业现状与未来发展蓝皮书
    17
    2023-07
    2023-07-17
  • 一文详解第四代基因测序技术
    17
    2023-07
    2023-07-17
  • 2023 IBI EXPO | 从成药谈到产业化,核酸、干细胞开发机遇和挑战干货
    17
    2023-07
    2023-07-17
  • 2023H1全球细胞疗法大事件TOP10
    17
    2023-07
    2023-07-17
  • 两年29个临床批件,干细胞疗法“井喷”,即将迎来黄金发展期?
    14
    2023-07
    2023-07-14
  • 新药研发到上市全流程(附投资思路)
    12
    2023-07
    2023-07-12
Prev
... 31 32 33 34
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号